Skip to Content
Merck
  • Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro.

Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro.

FEBS letters (1991-03-25)
M Murata, S Miyashita, C Yokoo, M Tamai, K Hanada, K Hatayama, T Towatari, T Nikawa, N Katunuma
ABSTRACT

A series of new epoxysuccinyl peptides were designed and synthesized to develop a specific inhibitor of cathepsin B. Of these compounds, N-(L-3-trans-ethoxycarbonyloxirane-2-carbonyl)-L-isoleucyl-L-proli ne (compound CA-030) and N-(L-3-trans-propylcarbamoyloxirane-2-carbonyl)-L-isoleucyl-L-prol ine (compound CA-074) were the most potent and specific inhibitors of cathepsin B in vitro. The carboxyl group of proline and the ethyl ester group or the n-propylamide group in the oxirane ring were necessary, the ethyl ester group or the n-propylamide group being particularly effective for distinguishing cathepsin B from other cysteine proteinases such as cathepsins L and H, and calpains.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
CA-074, ≥98% (HPLC)